Pre-operative concerns and post-operative satisfaction: comparing attitudes toward bariatric surgery and medication intervention for weight loss on Reddit.

Surgical endoscopy

GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder.

The Journal of clinical psychiatry

Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial.

Diabetes, obesity & metabolism

Management of patients with cardiovascular disease and overweight/obesity: expert opinion on semaglutide use.

Nutrition, metabolism, and cardiovascular diseases : NMCD

Coronary artery disease -related outcomes associated with semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis.

Nutrition, metabolism, and cardiovascular diseases : NMCD

Hyperuricemia, gout and obesity: should weight management be more of a focus in gout management?

Nutrition, metabolism, and cardiovascular diseases : NMCD

The most popular peptides in the research and biohacking world right now: → BPC-157 (healing) → TB-500 (recovery) → Retatrutide (fat loss) → Semaglutide & Tirzepatide (fat loss) → CJC-1295 + Ipamorelin (growth hormone) → Semax & Selank (focus)

i've been open about my personal journey with peptides and building at the forefront of longevity. at zelta we've helped over 570+ patients lose weight with GLP-1, while semaglutide is FDA-approved with clear regulation and data behind it, the wider peptide space runs on louder https://t.co/uI7ckgtmOp

our full reptides peptide tier list: S: - tirzepatide - semaglutide - retatrutide - liraglutide - orforglipron - tesamorelin - hgh - hcg - ghk-cu A: - ss-31 - pt-141 - survodutide - mazdutide - sermorelin - bpc-157 - tb-500 - cjc+ipa - cjc-1295 - ipamorelin - bpc+tb -

HANGİ PEPTİT HANGİ AMAÇLA KULLANILIYOR? Retatrutide — obezite ve metabolik hastalık araştırmaları (GLP-1/GIP/Glukagon agonisti) Tirzepatide — kilo kaybı ve tip 2 diyabet araştırmaları Semaglutide — iştah kontrolü ve glukoz metabolizması Cagrilintide — iştah baskılama ve kilo https://t.co/xIQdvyfWVt

The next 2 weeks could be the biggest stretch of 2026 for $HIMS. There are 2 major catalysts investors should be watching and understand. 1) FDA Compounded Peptide Advisory Meeting First, this is not the FDA’s final decision. Here’s how it works: - Independent experts https://t.co/JDEyZ1iIkZ

In 8 days the FDA decides the fate of the peptides half of biohacking Twitter is already taking. On July 23–24 it reviews seven of them: In 8 days the FDA decides the fate of the peptides half of biohacking Twitter is already taking. On July 23–24 it reviews seven of them: https://t.co/RGzXfWqBBx

Semaglutide and tirzepatide are often discussed as if they were interchangeable. They are not. Semaglutide targets the GLP-1 receptor. Tirzepatide targets both GIP and GLP-1 receptors, creating a different pharmacologic profile.

2/Despite discovering the first GLP-1 mechanism - semaglutide and later launching the first GLP-1 drugs Ozempic and Wegovy, Novo Nordisk $NVO has lost both its scientific and commercial leadership position in this lucrative $80B market after Eli Lilly’s $LLY lunched its own https://t.co/O76Ed3zOTv